Brynjelsen Sean 的 Form 4 申報
Eton Pharmaceuticals, Inc.ETON,2026/8/20 申報
- 申報編號
- 0001437749-26-028651
- 申報時間
- 2026/8/20 18:26 ET
- 交易日
- 2026/8/19-8/20
- 申報延遲
- 1 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $608.8 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Brynjelsen SeanCIK 0001669976 | 董事、高階主管(總裁、執行長) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 4 筆交易的價格引用這則附註。
- F3
The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price.
表 I 有 1 筆交易的價格引用這則附註。